Trial Profile
A Double Blind, Placebo Controlled 2-way Cross-over Study to Assess the Clitoral Engorgement Response as Measured by Non-contrast Magnetic Resonance Imaging (MRI) in Women With Female Sexual Arousal Disorder (FSAD) When Administered a Single Dose of Sildenafil (100mg) Followed by Audio/Visual Sexual Stimulation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 11 Apr 2008 New trial record.